Advertisements



Sage Therapeutics, Shionogi partner on development of SAGE-217 in Asia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Why Sage Therapeutics Is Booming

Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S.........»»

Category: blogSource: 247wallstJun 12th, 2018

Stifel confident in approval of Sage Therapeutics" brexanolone ahead of AdComm

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Sage Therapeutics started at outperform with $170 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 11th, 2018

Sage Therapeutics Larger Than S&P 500 Component Envision Healthcare

Market News Video.....»»

Category: topSource: redinewsOct 10th, 2018

Sage Therapeutics initiated with an Outperform at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Commit To Purchase Sage Therapeutics At $115, Earn 12.6% Using Options

Stock Options Channel.....»»

Category: topSource: redinewsSep 18th, 2018

Sage Therapeutics: The Lancet publishes data from pivotal trials of brexanolone

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 31st, 2018

SAGE Therapeutics, Inc. (SAGE) CEO Jeffrey Jonas on Q2 2018 Results - Earnings Call Transcript

SAGE Therapeutics, Inc. (SAGE) CEO Jeffrey Jonas on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 7th, 2018

Sage Therapeutics continues to make progress on Zulresso, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Sage Therapeutics transferred with a Buy at Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Sage Therapeutics reports Q2 EPS (36c), consensus ($1.89)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Sage Therapeutics initiated with an Overweight at Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2018

Commit To Buy Sage Therapeutics At $120, Earn 12.3% Using Options

Stock Options Channel.....»»

Category: topSource: redinewsJun 19th, 2018

Sage shares drop 3% after $90 mln Shionogi deal for key drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 14th, 2018

Benzinga"s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma"s Q4 Miss, Sage Inks Deal With Japan"s Shionogi

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hit.....»»

Category: earningsSource: benzingaJun 14th, 2018

Benzinga"s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma"s Q4 Miss, Sage Inks Deal With Japan"s Shionogi

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 13) read more.....»»

Category: blogSource: benzingaJun 14th, 2018

Sage Therapeutics price target raised to $220 from $210 at Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Brainstorm Health: Alzheimer’s Drug Failures, Sage Therapeutics Stock, Azar on Drug Prices

Brainstorm Health Daily: June 12, 2018 Good afternoon, readers--This is Sy. Of the diseases that regularly afflict millions upon millions of Americans, few have been quite as nefarious as .....»»

Category: europeSource: fortuneJun 12th, 2018

Sage Therapeutics to hold a conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Sage shares surge 4.5% on plan to expedite drug development for two types of depression

Sage Therapeu.....»»

Category: topSource: marketwatchJun 12th, 2018